The Centers for Medicare & Medicaid Services April 4 finalized changes to the Medicare Advantage and prescription drug ...

or about 14% of Medicare Part D’s prescription drug costs, according to CMS. The negotiated prices for the drugs will take effect in 2027. The second round of negotiations builds on the success ...

Evaluating current formulary access for the 25 drugs selected for Drug Price Negotiation in Medicare Part D shows several selected drugs have ...

Established under President Joe Biden’s Inflation Reduction Act of 2022, the Medicare Drug Price Negotiation Program allows ...

The Trump administration signaled Medicare drug price negotiations under the Inflation ... not total [Medicare parts B and D] spending,” Holz-Eakin told Health Care News. Under the IRA, CMS has the ...

The Inflation Reduction Act (IRA) may be restricting Medicare Part D formularies, increasing patient costs, and stifling ...

With the recent confirmation of Dr. Mehmet Oz as the new Administrator of the Centers for Medicare and Medicaid Services (CMS ...

A Connecticut federal judge has sided with the US Department of Health and Human Services (HHS) in Boehringer Ingelheim's challenge to Medicare’s drug price negotiation programme, rejecting the ...

Opens in a new tab or window Medicare was authorized to negotiate prices it will pay for Part D drugs. Enbrel ... Talks between CMS and drugmaker Amgen authorized under the Inflation Reduction ...

The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded ...

Administration officials reversed a decision made during the Biden presidency that would have given millions of people access ...